page header

HEOR & Safety

Gain Richer Insights about Clinical, Economic and Patient Outcomes

Leverage our innovative approaches to data collection and predictive analytics to help create purposeful datasets—and interpret the data to fit your specific needs.

Four areas of solutions:

  • Outcomes research
  • HE modeling
  • Pharmaco and drug safety
  • Commercial market access

Meet the Ever-Growing Demands of Regulatory Authorities

Meet the demands of regulatory authorities using our RWE experts, advanced capabilities in RWE management and analysis and proven experience in drug safety and epidemiology. We assist you in meeting the regulatory requirements for:

  • Conditional approval
  • Risk Evaluation and Mitigation Strategy (REMS)
  • Post-authorization safety studies (PASS)
  • EU risk management programs
  • Applicable pharmacovigilance legislation

Drive Powerful Insights and Faster Results with Enriched RWD


Combine the complementary approach of retrospective and prospective data collection to enrich your RWD. Our research includes:

  • Drug utilization and patient profiling
  • Burden of illness
  • Real-world resource use and costs
  • Compliance and persistence
  • Comparative effectiveness analysis
  • Patient-reported outcomes
  • Quality of life
  • Patient registries

More Successful Reimbursement, Sustainable Market Access and High-Impact Scientific Publications

Gain powerful and rigorous evidence-based health technology assessments using IMS Health's modeling solutions. Our models go through a structure validation and quality assurance procedure to ensure reliability.


  • Cost-effectiveness/utility models
  • Budget impact models for use in national and local market access negotiations
  • Interactive budget impact tools for field access use
  • Global core models and local adaptations
  • Early modeling

 Evidence Synthesis 

  • Systematic reviews
  • Meta-analyses
  • Network meta-analyses and mixed treatment comparisons

Support Product Value Propositions with Models Strengthened by RWD

Increase methodological rigor and generate new evidence to support product value propositions using IMS Health models strengthened by RWD

Example Projects

IMS Health RWD EMR—Linking detailed patient characteristics from clinical trials to healthcare resource utilization and patient outcomes for early economic remodeling

National Panel Datasets—Quantifying economic burden of disease by linking discrete datasets (e.g., Medical Expenditure Panel Survey, Nationwide Inpatient Sample) to record direct and indirect cost of disease

Commercial and Market Access

Scientific Credibility and Evidence Dissemination

3,000+ Publications 

Original and collaborative research from IMS Health has been widely published and presented in leading peer-reviewed journals and at major international conferences worldwide.

With a history of more than 25 years, our bibliography contains more than 3,000 publications spanning virtually all therapy areas and projects completed in more than 50 countries worldwide.

Interested in learning more about how IMS Health's HEOR & safety solutions can help you succeed? Let us know how we can help you: